Total (n = 61) | Alive (n = 49) | Death (n = 12) | Univariate p | Multivariate p | |
---|---|---|---|---|---|
Age | 0.539 | ||||
Age > =65 years | 9 | 8 | 1 | ||
Age < 65 years | 52 | 41 | 11 | ||
Gender | 0.427 | ||||
Men | 32 | 27 | 5 | ||
Women | 29 | 22 | 7 | ||
Hematological subtype | < 0.001 | 0.225 | |||
AML | 38 | 34 | 4 | ||
ALL | 13 | 8 | 5 | ||
Lymphoma | 7 | 5 | 2 | ||
CML/MPN | 1 | 1 | 0 | ||
CLL | 0 | 0 | 0 | ||
Myeloma | 1 | 1 | 0 | ||
MDS/SAA | 1 | 0 | 1 | ||
Preceding allogeneic transplantation | < 0.001 | 0.128 | |||
Yes | 5 | 1 | 4 | ||
No | 56 | 48 | 8 | ||
Neutropenia<=500 / mm3 | 0.650 | ||||
Yes | 19 | 16 | 3 | ||
No | 42 | 33 | 9 | ||
Thrombocytopenia | 0.905 | ||||
Platelet > = 20000 / mm3 | 52 | 42 | 10 | ||
Platelet < 20000 / mm3 | 9 | 7 | 2 | ||
Proven or Probable CDC | 0.492 | ||||
Yes | 16 | 12 | 4 | ||
No | 45 | 37 | 8 | ||
Initial anti-fungal agent | < 0.001 | 0.624 | |||
Amphotericin B | 9 | 7 | 2 | ||
Fluconazole | 35 | 29 | 6 | ||
Itraconazole | 1 | 0 | 1 | ||
Voriconazole | 6 | 6 | 0 | ||
Posaconazole | 2 | 1 | 1 | ||
Caspofungin | 1 | 0 | 1 | ||
Micafungin | 3 | 3 | 0 | ||
Anidulafungin | 2 | 1 | 1 | ||
none | 2 | 2 | 0 | ||
Hepatitis B carrier | 0.186 | ||||
Yes | 7 | 7 | 0 | ||
No | 54 | 42 | 12 | ||
Diabetes mellitus | 0.854 | ||||
Yes | 9 | 7 | 2 | ||
No | 52 | 42 | 10 | ||
Shock | < 0.001 | 0.016 | |||
Yes | 8 | 0 | 8 | ||
No | 53 | 49 | 4 |